Podcasts about diagnostics

Breakthrough science has never been stronger — yet patients still miss life-saving therapies.Despite decades of innovation, most precision medicines fail at the last mile of healthcare delivery.The problem isn't discovery. It's how science, capital, and systems are aligned — or not.Possessing elite science is no longer enough to win in the multi-trillion-dollar biopharma ecosystem.As innovation shifts from West to East and from treatment to prevention, leadership teams struggle to bridge scientific depth with incentives, execution, and real-world delivery. Capital follows speed and scale — not intention — and healthcare systems built decades ago are failing to keep up.In this episode, Alasdair Milton, Principal at KPMG, explains where innovation actually breaks — and what must change for cures to reach patients at scale. From diagnostics and data silos to capital allocation and prevention models, this conversation reframes the next decade of precision medicine.

As part of our official DealFlow Discovery Conference Interview Series, produced by Mission Matters, along with our partner DealFlow Events, we're showcasing the innovative companies presenting at the DealFlow Discovery Conference and the executives behind them. ---- In this episode, Adam Torres interviews Ilan Danieli, CEO of Precipio, about the company's mission to reduce cancer misdiagnosis—especially in complex blood-related cancers. Ilan explains how Precipio partners with academic experts to expand access to subspecialty pathology, why accuracy matters more than speed, and how better diagnostics can directly change treatment decisions and patient outcomes. About Ilan Danieli Ilan Danieli has served as Precipio's CEO since founding the company in early 2011. With over 20 years managing small and medium-size companies, some of his previous experiences include COO of Osiris, a publicly-traded company based in New York City with operations in the US, Canada, Europe; Laurus Capital Management, a multi-billion dollar hedge fund; and in various other entrepreneurial ventures. Ilan holds an MBA from the Darden School at the University of Virginia, and a BA in Economics from Bar-Ilan University in Israel. Ilan has a private pilot license, plays the saxophone, and possesses infinite love for his horses. About Precipio Precipio's platform delivers superior diagnostic accuracy through academic expertise and cutting edge technology. They are a laboratory focused on delivering specialized diagnostic services to physicians and their patients to ensure they receive accurate results. Watch Full Episode on ⁠Youtube⁠. --- This interview is part of our effort to help investors discover compelling companies ahead of the event — and to help CEOs introduce their story to the 1500+ conference attendees. Learn more about the event and presenting companies: ⁠⁠https://dealflowdiscoveryconference.com/⁠ Follow Adam on Instagram at ⁠https://www.instagram.com/askadamtorres/⁠ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: ⁠https://missionmatters.lpages.co/podcastguest/⁠ Visit our website: ⁠https://missionmatters.com/⁠ More FREE content from Mission Matters here: ⁠https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices

Start making $150k - $200k+ in your first year of medical sales. Stop chasing crowded "old school" roles like Orthopedics and Spine. The real money—and the life-saving innovation—is in Oncology and Specialty Pharma. Today, I reveal the exact blueprint to reinvent your career and break into the most lucrative sector of healthcare. Whether you're a nurse, a teacher, or stuck in a "middle-class mindset," this episode breaks down why your background doesn't matter. Only your preparation does.I share my personal journey from a non-profit minister making $70k to a high-level oncology rep, and explain why "casual advice" from friends will get you rejected. If you want to master the interview, crush your clinical knowledge, and build a 6-figure life, this is the masterclass you need.WHAT YOU WILL LEARN IN THIS EPISODE:- The "Gold Rush" Shift: Why you should ignore Orthopedics and focus entirely on Oncology, Diagnostics, and Genetic Testing.- The 3 Essential Mindset Shifts: How to move from "winging it" to becoming an obsessively prepared candidate.- Real Success Stories: How Kanika (immigrant to Dallas), Sydney (nurse), and others went from zero experience to $200k roles.- The "Ride-Along" Trap: Why you need a brutal coach, not a nice mentor.- The HEART Framework: The 5 character traits (Humility, Energy, Active Listening, Resilience, Trust) that hiring managers look for.- Confidence vs. Arrogance: How to show "grit" without sounding like a jerk.- Daily Habits of Top 1% Earners: The 5 AM club, the "20 LinkedIn adds" rule, and why your degree (MBA) has a lower ROI than coaching.- The Michael Jordan Rule: Why even the greatest of all time hired coaches for their specific weaknesses.TIMESTAMPS00:00 - Introduction: The Program Focus (Oncology vs. Orthopedics)01:34 - Dave's Story: Reinventing Career from Ministry to Medical Sales03:44 - Success Stories: How Nurses & Immigrants Got Hired (Kanika, Sydney)06:47 - Mindset Shift #1: Be Coachable (Why Friends Can't Help You)09:20 - Mastering Virtual Interviews (Lighting, Camera & Background)10:32 - Mindset Shift #2: Be Curious (Understanding Clinical Trials & FDA)12:32 - Salary Reality: Device Associate ($80k) vs. Oncology ($155k+)13:55 - Mindset Shift #3: Collaboration (Working with MSLs & Nurse Navigators)16:28 - Confidence vs. Arrogance (The "Grit" Trap)18:02 - The H.E.A.R.T. Framework (Humility, Energy, Listening, Resilience, Trust)19:00 - Daily Habits: 5 AM Wake-ups, LinkedIn Strategy & Handling Rejection20:00 - The"Middle Class Mindset" Trap: Why Degrees Have Low ROI22:25 - Using AI for Resumes Without Sounding Like a Robot25:55 - The "Why": Patient Outcomes & Life-Extending Impact29:35 - The 3 Questions You Must Ask Yourself31:01 - The Michael Jordan Analogy: Why Even the Best Hire Coaches.ABOUT MEDICAL SALES U: Medical Sales U is the premier training program for professionals looking to break into high-paying careers in Medical Device, Pharmaceutical, and Genetic Testing sales. We turn "outsiders" into top 1% candidates.CONNECT WITH US: Learn more about coaching and career support at medicalsalesu.com/#MedicalSales #OncologySales #CareerPivot #SalesCoaching #HighIncomeSkills #DaveSterrett #MedicalSalesYou #InterviewTips #SalesJobs #PharmaceuticalSales

In this episode, Sam Ashoo, MD and T.R. Eckler, MD discuss the December 2025 Emergency Medicine Practice article, Diagnosis and Management of Cannabis-Related EmergenciesEpisode Outline: [0:00] IntroductionWelcome and show overview by Sam AshooMention of resources at ebmedicine.net[0:46] Episode StartHosts introduce themselves: Sam Ashoo and Dr. T.R. EcklerDr. Eckler's background and experience with cannabis cases in Colorado[1:16] Topic IntroductionFocus on diagnosis and management of cannabis-related emergenciesPrevalence and importance in emergency medicine[1:34] Legal LandscapeOverview of cannabis legality across statesMedicinal vs. non-medicinal use[3:03] Increase in ED VisitsStatistics: ~1 million cannabis-related ED visits annuallyDemographics: younger population most affected[3:52] Synthetics and ChallengesDiscussion of synthetic cannabinoids and their risksIssues with detection and legality[4:50] Clinical SpectrumRange of presentations: from nausea/vomiting to psychosis and seizuresImpact on different age groups[6:34] FDA-Approved UsesCannabis-derived products approved for specific medical conditions[7:20] Physiology and PathophysiologyCannabinoid receptors (CB1 and CB2) and their effectsDifferences between plant-derived and synthetic cannabinoids[9:10] Chronic Use and WithdrawalDownregulation of receptors, withdrawal symptoms, and persistent nausea[10:20] Product Forms and Delivery MethodsSmoking, edibles, oils, tinctures, suppositories, topicals, etc.Risks associated with concentrated forms (e.g., wax, oils)[12:00] Clinical Effects by SystemPsychiatric: anxiety, psychosis, paranoiaCardiovascular: tachycardia, MI risk, QT prolongationPulmonary, renal, metabolic, dental, and ocular effects[13:50] Cannabinoid Hyperemesis Syndrome (CHS)Phases: prodrome, hyperemesis, recoveryHot showers as a diagnostic clue[16:00] Withdrawal SyndromeSymptoms and timelineExacerbation with synthetic cannabinoids[18:15] Counseling and ManagementImportance of cessation and patient educationTimeline for symptom improvement[18:42] Differential DiagnosisBroad differential for persistent nausea/vomiting and abdominal painImportance of considering other causes[20:55] Diagnostics and TestingLimitations of drug screens (false positives/negatives)Importance of EKG, labs, and imaging as indicated[23:10] Treatment ApproachesFirst-line: benzodiazepines, antiemetics (ondansetron, metoclopramide)Second-line: butyrophenones (haloperidol, droperidol), olanzapineCapsaicin as adjunct therapy[29:50] Complications and Special ConsiderationsRisks of undertreatment (e.g., Boerhaave syndrome, aspiration)Pediatric and pregnant populations: unique risks and reporting requirements[36:00] Five Practice-Changing TakeawaysElicit cannabis use historyKnow testing limitationsConsider ECG and appropriate labsUse butyrophenones when indicatedAdmit if symptoms are refractory[39:00] ConclusionEmergency Medicine Residents, get your free subscription by writing resident@ebmedicine.net

Graham Rigby is the President and CEO of the American Herbal Products Association (AHPA), the leading trade association for the herbal products industry. With 20 years of experience across startups and industry leadership—including serving as Chief Innovation Officer at Care/of—Graham has helped shape how modern supplement brands navigate regulation, formulation, and go-to-market strategy.In this episode of DTC Pod, Graham shares what it actually takes to launch and scale a supplement brand without getting burned by regulators. He breaks down exactly where the line is between claims that sell and claims that get you in trouble, why so many founders get blindsided by FDA and FTC enforcement, and how to work with contract manufacturers when you're just starting out. Graham also gets into the real opportunity in supplements right now—why clinical trials cost 90% less than they did two decades ago, how AI is changing the formulation game, and why a $70 billion market growing at 6.5% still has plenty of room for new entrants. Plus, his take on the brands that are doing it right, from AG1 to Ritual, and what founders can learn from their playbooks.Episode brought to you by StordInteract with other DTC experts and access our monthly fireside chats with industry leaders on DTC Pod Slack.On this episode of DTC Pod, we cover:1. The evolution and growth of the herbal supplement industry2. Key regulatory milestones: DSHEA, GMPs, and FDA compliance for supplements3. What founders must do to stay compliant when launching a supplement brand4. The distinction between pharmaceuticals, dietary supplements, and nutraceuticals5. Marketing, claims, and the importance of substantiation6. Emerging opportunities with clinical trials and claim innovation7. DTC, Amazon, TikTok, and brick-and-mortar distribution channels for wellness brands8. The practicalities and risks of supplement retail (and when to scale beyond DTC)9. Practitioner and non-traditional channels for supplement sales10. How Ingredient AI, Infinite Garden, and other platforms are applying AI to supplements11. Content creators, credentialed doctors, and the new face of trusted health advice12. The role of diagnostics, wearables, and personalization in driving supplement trends13. Growth outlook: Why the supplement market is just getting startedTimestamps00:00 Intro to DTC POD and Graham Rigby02:25 20 years of supplements: Startup vs. regulatory side03:00 The exponential growth of the herbal products market04:44 Regulatory basics: DSHEA, FDA oversight, and GMPs explained07:14 How AHPA helps brands navigate compliance and education08:03 Launching a supplement brand: Key compliance steps and best practices10:00 FDA's post-market regulatory process and founder responsibilities13:04 Supplements vs. pharmaceuticals: Safety, claims, and approvals17:32 Telling stories and using clinical research for marketing claims20:00 What marketers can and cannot say: Health vs. disease claims22:04 Substantiating claims and the importance of compliance for growth24:31 Label vs. online claims: How rules apply to different channels27:02 DTC vs. Amazon, TikTok, and expanding to retail and practitioner channels30:19 The risks and rewards of brick-and-mortar expansion35:14 AI and technology's role in supplement industry efficiency and safety40:47 The rise of content creators and doctors shaping supplement education46:34 Diagnostics, wearables, and the future of personalized wellness51:13 Supplement industry outlook and advice for emerging brands52:25 How to connect with Graham and AHPA, and upcoming founder programsShow notes powered by CastmagicPast guests & brands on DTC Pod include Gilt, PopSugar, Glossier, MadeIN, Prose, Bala, P.volve, Ritual, Bite, Oura, Levels, General Mills, Mid Day Squares, Prose, Arrae, Olipop, Ghia, Rosaluna, Form, Uncle Studios & many more.  Additional episodes you might like:• #175 Ariel Vaisbort - How OLIPOP Runs Influencer, Community, & Affiliate Growth• #184 Jake Karls, Midday Squares - Turning Your Brand Into The Influencer With Content• #205 Kasey Stewart: Suckerz- - Powering Your Launch With 300 Million Organic Views• #219 JT Barnett: The TikTok Masterclass For Brands• #223 Lauren Kleinman: The PR & Affiliate Marketing Playbook• ​​​​#243 Kian Golzari - Source & Develop Products Like The World's Best Brands-----Have any questions about the show or topics you'd like us to explore further?Shoot us a DM; we'd love to hear from you.Want the weekly TL;DR of tips delivered to your mailbox?Check out our newsletter here.Projects the DTC Pod team is working on:DTCetc - all our favorite brands on the internetOlivea - the extra virgin olive oil & hydroxytyrosol supplementCastmagic - AI Workspace for ContentFollow us for content, clips, giveaways, & updates!DTCPod InstagramDTCPod TwitterDTCPod TikTokGraham Rigby - President & CEO of American Herbal Products Association (AHPA)Blaine Bolus - Co-Founder of CastmagicRamon Berrios - Co-Founder of Castmagic

When growth stalls, it's time to get personal.  Ever felt like you've done all the "right" things in your business, but your results don't add up? You're not alone. In this episode of Your Passion, Purpose, and Personal Brand, host Lisa McGuire sits down with business strategist Maeve Ferguson to challenge everything we've been told about marketing funnels, freebies, and formulas. They explore the quiet revolution happening behind the scenes that few people know about yet. It's one driven by data, dignity, and diagnostics. This is not another pep talk. This is a call to alignment. You'll learn why personalization is the new currency in business, how traditional funnels are quietly failing, and what it really takes to attract high-level clients without selling your soul (or your calendar) to outdated discovery calls. Maeve reveals how entrepreneurs are collapsing months of guesswork into clarity by transforming their intellectual property into score-based diagnostics that do more than convert. They connect. If you've ever whispered to yourself, "I know I'm meant for more...but I don't know where I lost the map," this conversation is your compass. KEY TAKEAWAYS Traditional funnels are outdated. Today's audiences crave personalization. Diagnostic assessments segment leads for higher precision and conversions. Mass emails and checklist freebies often repel rather than attract. Your audience's sophistication has evolved. It's time your strategy does too. Diagnostics let you identify who's truly ready and willing to buy. Rich niche positioning attracts elevated clients and filters out misaligned ones. Mapping your IP (yes, you have it) gives clarity, confidence, and authority. AI and mediocrity are flooding the market. Your differentiation is being real. When you stop chasing and start aligning, sales become symphonic. Success is not about "doing more." It's about becoming more of who you are.   CONNECT WITH MAEVE LinkedIn Profile: https://www.linkedin.com/in/maeveferguson/ Instagram Profile: https://www.instagram.com/iammaeveferguson/ Website: www.maeveferguson.com  CHECK OUT MAEVE'S FREE RESOURCE: https://www.impactscoreassessment.com   CONNECT WITH LISA Beyond the Transaction Mastermind -  Apply to join the group: https://beyondthetransactionmm.com/register Sign up for Lisa's "so much more" newsletter: https://www.thediyframework.com/so-much-more-subscribe  Freedom Reset: Your Next Steps to Realignment  Register: https://go.lisamcguire.com/freedom-reset  Human Design Masterclass Waitlist: https://go.lisamcguire.com/human-design-masterclass-waitlist  Ideal Client Workshop Waitlist: https://go.lisamcguire.com/ideal-client-workshop-waitlist-icww785155  Get your free Human Design Bodygraph: https://lisamcguire.com/get-your-free-chart/   

Mike Nemer interviewed Kevin Carriere, the CEO of Powertron Global, who explained that he entered the HVAC industry after meeting engineers developing solutions for heat exchanger efficiency restoration. On episode 310 of The Green Insider podcast, Kevin described how Powertron Global was founded to address HVAC efficiency issues, expanding beyond initial heat exchanger solutions to tackle other efficiency-robbing factors in climate control systems. Todays podcast includes: Sustainable HVAC Efficiency Restoration Sustainable HVAC practices can lead to cost savings, not just environmental benefits. HVAC systems lose efficiency over time, mainly due to heat exchanger capacity loss, which increases energy use and maintenance. Powertron engineers developed a heat exchanger restoration technology to restore lost efficiency, filling a gap in the industry. Craftsmanship and education on efficiency restoration are crucial, especially for city and government agencies. HVAC Efficiency Diagnostics Platform Most HVAC systems, especially in taxpayer-funded facilities, operate 30–40% below their intended design capacity. Powertron created a proprietary forensic measurement and verification platform, collecting data from over 400 studies in 38 countries. The company focuses on restoring system capacity and providing diagnostic data to manufacturers and researchers, serving clients like cell tower huts, convenience stores, and government facilities. HVAC Efficiency Loss Over Time New HVAC systems lose 5–7% efficiency in the first year (with proper maintenance), then 3–4% annually, reaching a 25–30% reduction over time. Systems in regions with long cooling seasons (eastern/western US) can lose significant efficiency in 3.5–5 years; in the Midwest, it takes about twice as long. Rooftop units expected to last 15 years are often replaced in 10 due to efficiency loss and increased runtime. Type System ROI and Sustainability The ROI for Powertron's type system is typically 12–18 months, but as short as 3 months for mission-critical sites (e.g., data centers, hospitals). The goal is to restore systems to their design capacity, improving efficiency and generating further savings. Certified reports are provided to quantify emissions reductions and energy savings, which can be used in customers' sustainability reports. To be an Insider Please subscribe to The Green Insider powered by ERENEWABLE wherever you get your podcast from and remember to leave us a five-star rating. This podcast is sponsored by UTSI International. To learn more about our sponsor or ask about being a sponsor, contact ERENEWABLE and the Green Insider Podcast. The post Maximizing HVAC Efficiency: Sustainable Restoration, Diagnostics, and ROI appeared first on eRENEWABLE.

Health care executive Kevin King discusses his article, "How to stay safe from back-to-school illnesses." Kevin explains why the return to classrooms often triggers a surge in respiratory illnesses (like the flu, COVID-19, and RSV) and how diagnostic tests are a critical tool for managing them. He highlights how rapid diagnostics are essential for getting the right treatment quickly, such as antivirals, and perhaps more importantly, for preventing the wrong treatment, which helps combat the growing threat of antibiotic resistance. Kevin also offers insight into how epidemiologists predict outbreaks by monitoring school absenteeism and data from the Southern Hemisphere, providing a fascinating look at community health surveillance. Discover how early and accurate testing serves as our frontline defense in protecting vulnerable populations and managing respiratory illnesses this school season. Our presenting sponsor is Microsoft Dragon Copilot. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Now you can streamline and customize documentation, surface information right at the point of care, and automate tasks with just a click. Part of Microsoft Cloud for Healthcare, Dragon Copilot offers an extensible AI workspace and a single, integrated platform to help unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise, and it's built on a foundation of trust. It's time to ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

We are in our 3rd week of our 4-part series on the #1 killer in America.   And we're talking about the Diagnostics that Dr. Prather uses to get to the root cause of Cardiovascular Disease. In this episode, you'll learn:—How Diagnostics are "even more important and more complete" in the Structure-Function Health Care model than in Disease Care.—Why the electrical system of the Heart is so important.   And how Dr. Prather uses what he considers "the best" in Holter monitors to measure a patient's electrical system.—The way a patient's EKG will completely normalize though the therapeutic exercise External CounterPulsation (ECP) Therapy at Holistic Integration .—The impact of the Nervous System on the Heart's electrical system, which can be improved through Chiropractic care.  And the way Holistic Integration measures the Vagus Nerve and the Parasympathetic and Sympathetic balance through their Autonomic Nervous System (ANS) Test. —Why Minerals are "critical" to the electrical system of the Heart.  And how Minerals are best measured through Hair Analysis and Bloodwork. —The amazing story of the patient whose WATCH was throwing off his heart's electrical system. —How Dr. Prather sees many Heart problems cleared up by clearing Heavy Metals out of people.—Why getting to the root cause of a patient's Heart problem is "like detective work". —The link between infections and Cardiovascular Disease, such as the Coxsackie B virus which can cause Cardiomyopathy.  And how infections, most commonly Strep, can also cause Heart Valve Issues.—How the Heart CAN be healed and has an amazing ability to regenerate.http://www.TheVoiceOfHealthRadio.com*Receive exclusive bonus content as a member of our Voice Of Health Patreon Community:https://www.patreon.com/cw/VoiceofHealthPodcast

his podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com A fingertip-sized blood sample may soon replace the needle stick millions of patients avoid every year. In this episode, Web Golinkin, President of Babson Diagnostics, shares how Better Way, a fingertip blood collection system, is redefining convenience, accuracy, and accessibility in diagnostic testing. He explains how the company spent nearly a decade validating its technology through 45+ IRB-approved studies, 4,300+ participants, and more than 850,000 tests to ensure clinical equivalence to venous draws. He traces the innovation's journey from a Siemens skunkworks project to partnerships with BD and a 510(k)-cleared device, culminating in an 80% primary-care test menu from a pea-sized sample. He also highlights how Better Way improves adherence, enhances patient and staff experience, and reduces friction with clear, graphical results. Tune in and discover how fingertip testing can transform preventive care, patient engagement, and healthcare operations! Resources Connect with and follow Web Golinkin on LinkedIn. Follow Babson Diagnostics on LinkedIn and visit their website!

Anne Zink is a lecturer and senior fellow at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.B. Zink, N.C. McCann, and R.P. Walensky. From Crisis to Action — Policy Pathways to Reverse the Rise in Congenital Syphilis. N Engl J Med 2025;393:2388-2391.

Dans cet épisode, je te parle des diagnostics tardifs et de leur impact sur l'identité et la compréhension de soi. J'explique pourquoi certaines personnes reçoivent un diagnostic de TDL, TDAH ou TSA seulement à l'adolescence ou à l'âge adulte. Je partage aussi mon point de vue sur l'importance de mieux comprendre son propre fonctionnement cognitif, même en l'absence d'un diagnostic formel, afin d'adopter des stratégies adaptées et de réduire l'impact fonctionnel. Mon site web Instagram Facebook Mon infolettre Liens : Découvre le podcast de Stéphanie Boulay, Apparaître : la neurodivergence invisible  

Thanks to our Partners, NAPA Auto Care and NAPA TRACS Watch Full Video Episode Eric Svedberg breaks down a smarter, more profitable way to price diagnostic work—what he calls the Level Testing Sales Amplifier. At its core, the system tackles a problem most repair shops quietly accept: testing is often a loss leader. When technicians are tied up diagnosing complex issues, shops miss out on parts sales. A-level technicians can earn less than their B-level counterparts doing routine work, and the rising cost of software and tools goes unpaid. Svedberg reframes the conversation by using the word “testing” instead of “diagnostics,” a term he believes is clearer and more intuitive for customers. Testing implies a process, not a guarantee—setting expectations from the start. The Level Testing system uses a tiered structure tied to the shop's base labor rate: Level One – Basic Testing:Single, constant, duplicable issues (like a check engine light that's always on).Level Two – Intermediate Testing:Multiple concerns or intermittent problems.Level Three – Pandora's Box:Highly complex vehicles, often previously misdiagnosed or unsuccessfully repaired elsewhere.Level Four – “Grandmother Rate”:Disaster cars involving severe electrical damage, corrosion, or major disassembly. While the levels are designed as an internal framework, Svedberg finds transparency with customers increases trust and buy-in. Service advisors are coached to remove Level Three from most conversations upfront, steer customers toward Level Two testing as the norm, and clearly explain that testing fees are for time spent—not credited toward repairs. For true Level Three cases, advisors frame the value honestly: if it were simple, another shop would have already fixed it. Svedberg emphasizes that the system is easy to train and implement—often within a week—by focusing on quick wins with top advisors. Its simplicity improves communication, closes the tech efficiency gap, and can be applied beyond diagnostics to services like module programming and ADAS calibration. Every decision, he says, must pass the test: Is it good for the car? Good for the customer? Good for the shop? Eric Svedberg, European Autowerks, Virginia Beach, VA, https://www.gofuelcoaching.com/ , https://www.europeanautowerks.com/ Thanks to our Partners, NAPA Auto Care and NAPA TRACS Learn more about NAPA Auto Care and the benefits of being part of the NAPA family by visiting https://www.napaonline.com/en/auto-care NAPA TRACS will move your shop into the SMS fast lane with onsite training and six days a week of support and local representation. Find NAPA TRACS on the Web at http://napatracs.com/ Connect with the Podcast: -...

About James York:James York serves as the Chief Commercial Officer and Head of Government Affairs at Molecular Testing Labs, where he leads the company's mission to expand access to diagnostics and transform patient engagement with their health. With over a decade of leadership experience at the organization, James drives commercial strategy, strategic partnerships, business development, and market education, championing a consumer-centric approach to laboratory medicine. His work focuses on advancing transparency, affordability, and proactive health management by ensuring that individuals, regardless of their circumstances or geography, can benefit from timely diagnostic insights. James' career spans executive roles across healthcare, including CEO and president positions, as well as senior leadership in sales and business development, providing him with a deep understanding of both clinical and commercial landscapes. Guided by a commitment to equitable access and meaningful innovation, he continues to influence how advanced diagnostics are delivered and adopted across the healthcare ecosystem.Things You'll Learn:Making diagnostics accessible requires removing economic, geographic, and emotional friction so patients can participate in their own care. At-home self-collection solves barriers that traditional labs cannot.Affordability is inseparable from access, and transparent low-cost testing is critical for supporting large populations who are “functionally uninsured.” Most patients avoid care because they cannot predict the financial burden.Virtual care has accelerated the need for decentralized diagnostics, as patients who seek care online are unlikely to travel to a physical laboratory. Without accessible testing, virtual clinical pathways break.Pioneering new diagnostic models is challenging, costly, and often met with resistance from incumbents and regulators. Yet these challenges highlight the significance of the innovation.The greatest opportunity in diagnostics lies not in high-tech breakthroughs but in improving everyday tests that influence most clinical decisions. Access, not technology, is the true innovation.Resources:Connect with and follow James York on LinkedIn.Follow Molecular Testing Labs on LinkedIn and visit their website. 

Are you trying to break into medical sales but stuck deciding between Pharmaceutical and Medical Device? Or maybe you're curious about the high-growth world of Diagnostics and Genomics?Today, we discuss the differences in pay, lifestyle, and entry-level requirements for each path. Whether you want the adrenaline of the Operating Room or the stability of a $130k+ base salary in Pharma, this episode covers the 12 key distinctions you need to know before applying. IN THIS EPISODE YOU WILL LEARN:The Personality Test: Why "Engineers" love Device and "Scientists" love Pharma.The Paycheck: Real breakdown of base salaries vs. uncapped commissions.The Hidden Third Option: Why Oncology Diagnostics/Genomics might be the "Goldilocks" career path.Work-Life Balance: The reality of on-call surgical hours vs. the 9-to-5 pharma life.Success Stories: How a nurse (Sydney) and an immigrant (Kanika) broke in with $150k-$200k packages.READY TO BREAK IN? If you are struggling to get offers or don't know where to start, we help people from all backgrounds (nurses, coaches, teachers) launch their medical sales careers.Apply to Medical Sales U at medicalsalesu.com/TIMESTAMPS:00:00 - Intro: The common dilemma (O.R. vs. Samples).01:06 - The 3 Paths: Pharma, Device, and Diagnostics.02:15 - Science vs. Engineering: Which fits your brain?04:35 - Salary Reveal: Entry-level Pharma Pay ($95k-$135k base).06:10 - The "Associate" Role: Why Device base pay starts lower.07:40 - The Top 1%: Earning potential ($300k - $750k).09:15 - Diagnostics Pay: The sweet spot?10:30 - The Sales Process: Who are you actually selling to?13:50 - Lifestyle Check: Early mornings vs. Family flexibility.17:15 - Career Advancement: From Rep to Regional Director.22:15 - Student Success: From $68k to $200k total comp.ABOUT MEDICAL SALES U: Medical Sales U is the premier training program for professionals looking to break into high-paying careers in Medical Device, Pharmaceutical, and Genetic Testing sales. We turn "outsiders" into top 1% candidates.CONNECT WITH US:Learn more about coaching and career support at medicalsalesu.com/#MedicalSales #PharmaceuticalSales #MedDevice #SalesCareer #DaveSterritt #CareerAdvice #HighPayingJobs #SalesTips

AABP Executive Director Dr. Fred Gingrich is joined by Dr. Angel Abuelo, AABP member on faculty at Michigan State University College of Veterinary Medicine. Abuelo presented at the 2025 AABP Recent Graduate Conference in Norman, Okla. on managing Salmonella Dublin. AABP members can listen to this presentation for free by accessing the online CE portal on this page or download the BCI Mobile Conference app from your device's store.  Salmonella Dublin is a host-adapted pathogen that results in high morbidity and mortality due to the systemic nature of the disease in calves and in most cases, the pathogen exhibits multi-drug resistance. This pathogen also has implications for human health as a zoonotic disease. Abuelo discusses the clinical presentation in calves is primarily respiratory disease and the carrier state that can be seen in adult cows that serve as a continuous reservoir to maintain the disease on a farm. Diagnostics should include multiple tissues from deceased calves that are necropsied. The best sample to submit in live calves is not feces, but aseptically collected blood cultures.  Abuelo discusses the nuances of treatment in affected calves and due to multi-drug resistance, response to therapy can be poor or lead to a carrier state in recovered animals. Although enrofloxacin is labeled for treatment of bovine respiratory disease, it is not specifically labeled for treatment of Salmonella Dublin and extralabel use of fluoroquinolones in food animals is prohibited by the FDA.  Prevention of the disease is multifactorial and includes all aspects of proper neonatal calf management including adequate and timely pasteurized colostrum, maternity pen management, ventilation, sanitation and nutrition. Abuelo also discusses the use of vaccines in cows and calves to manage the disease on endemically infected farms to prevent outbreaks. Continued research on managing this disease, including the use of vaccines and improved diagnostics, will be important topics for veterinarians and producers who are managing this pathogen. REFERENCES: Frye E, Jennings C, Kremer K. Aseptic technique for blood culture collection in the field to diagnose Salmonella Dublin in calves. J Am Vet Med Assoc. 2025;263(7):1. https://doi.org/10.2460/javma.25.02.0116. PMID: 40267971. https://avmajournals.avma.org/view/journals/javma/263/7/javma.25.02.0116.xml Castro-Vargas RE, Cullens-Nobis FM, Mani R, Roberts JN, Abuelo A. Effect of dry period immunization of Salmonella Dublin latent carriers with a commercial live culture vaccine on intrauterine transmission based on the presence of precolostral antibodies in offspring. J Dairy Sci. 2024;107(12):11436-11445. https://doi.org/10.3168/jds.2024-24945The effect of Salmonella vaccination on Salmonella Dublin blood enzyme-linked immunosorbent assay results. Bov Pract. 2025;59(2), 53-60. https://doi.org/10.21423/bpj20259266 Abuelo A, Renaud D.  Salmonella Dublin Infection in Cattle. Merck Veterinary Manual. 2024. Winter A, Abuelo A, Allen DG, et al. (Eds). Merck, Rahway, NJ, USA. https://www.merckvetmanual.com/digestive-system/salmonellosis/salmonella-dublin-infection-in-cattle Salmonella Dublin Risk Management HERD SD app: https://apps.apple.com/us/app/herd-sd/id6748356498   

In this episode, Eric Malzone sits down with Dr. Ryan Greene, founder and CEO of Monarch Athletic Clubs. Dr. Greene shares his journey from exercise physiology and medical training to creating an all-in-one health club designed for true wellness—not just fitness. They dive into why our healthcare system is really a "sick care" system, how Monarch integrates medicine, personal training, recovery, and community under one roof, and the surprising reason their clubs stayed open during the pandemic. Dr. Greene also opens up about the future of longevity, the problem with having data but no actionable plan, and why mental health and authentic community are the next frontiers in health.

Sponsored by the Institute for Functional Nursing (IFN) www.fxnursing.com In this episode, Brigitte interviews Ryan Obermeier of Evexia Diagnostics to show nurses exactly how to streamline functional lab testing inside a holistic or functional nursing practice. We break down how Evexia centralizes thousands of functional and specialty tests, simplifies ordering, integrates with systems like Practice Better, and reduces the administrative burden that often slows down new and growing practices. Ryan explains Evexia's Internal Physician Network, which supports nurses who need physician authorization for specialty testing, as well as the Ask the Doctor program for clinical interpretation of advanced labs. We also cover Evexia's Functional Health Report, supply management, troubleshooting support, white-label marketing tools, and how nursing using the link below can access exclusive perks, waived fees, and discounted resources. Whether you're launching a functional nursing practice or scaling an established clinic, this episode gives you a clear roadmap for improving efficiency, patient outcomes, and clinical confidence through better lab workflows. What We Cover in This Conversation: • How Evexia centralizes thousands of functional & specialty lab tests • Streamlined ordering, processing, and automated reporting • EHR integration with Practice Better and other platforms • Functional Health Report for blood chemistry interpretation • Internal Physician Network for non-licensed or collaborating providers • Ask the Doctor program for specialty lab interpretation • Reducing hidden costs, operational friction, and admin overwhelm • White-label and marketing tools available through the link below • How nurses can register and access waived fees + bonus support Functional Nurses Offer: Register With Evexia Diagnostics Evexia is extending exclusive benefits for our functional nursing community of RNs and NPs, including waived fees and access to additional support tools. Create your account here: https://www.evexiadiagnostics.com/lp/brigitte-sager-landing-registration-page

About Web Golinkin:Web Golinkin is a seasoned healthcare executive, entrepreneur, and author with more than 35 years of leadership experience, including six CEO roles and three companies he co-founded. Over the last two decades, he has focused on expanding access to affordable, basic healthcare, establishing himself as a pioneer in both retail-based clinics and urgent care. His insights into the evolution of consumer-focused healthcare have been featured in The Wall Street Journal, Forbes, The Today Show, Fox Business, and numerous industry conferences. Web is also the author of Here Be Dragons, published by Forbes Books in 2024. His career spans leadership positions across healthcare delivery, population health management, medical communications, and consumer health media, including his current role as president of Babson Diagnostics and previous leadership at FastMed Urgent Care, Health Dialog, RediClinic, America's Health Network, and American Medical Communications. A graduate of Harvard University, Web continues to shape the future of healthcare through innovation, accessibility, and patient-centered design.Things You'll Learn:Better Way can deliver 67 clinically equivalent tests from a fingertip blood sample, covering more than 80% of common primary care needs. This allows patients to avoid the traditional needle-based blood draw.Nearly a decade of validation, including thousands of study participants and hundreds of thousands of tests, demonstrates the scientific rigor behind the technology. This long research runway enabled FDA clearance and strong clinical confidence.About one-third of patients avoid blood testing due to needle phobia or inconvenience, contributing to major gaps in preventive care. A more straightforward, painless collection method directly addresses this barrier.Health systems can increase patient adherence and reduce reliance on phlebotomists by cross-training staff to use the system within 2.5 hours. This unlocks staffing flexibility and operational efficiency.Better Way focuses on reducing friction across the entire testing journey, including simplified, graphic-rich patient result reports. This empowers patients to understand their health without having to decipher complex medical language.Resources:Connect with and follow Web Golinkin on LinkedIn.Follow Babson Diagnostics on LinkedIn  and visit their website.

Host Dr. Linda Chu speaks with Dr. Jana Ivanidze and Dr. Rajiv Magge about how molecular imaging is transforming the diagnosis and management of breast cancer brain metastases, with an emphasis on precision and personalized care. Their discussion highlights emerging tools such as advanced PET techniques and liquid biopsy that support earlier detection, guide treatment planning, and shape the future of neuro-oncology. Sponsored by GE HealthCare.      

Vrajesh Pandya. Transdermal GFR Signals a New Horizon in Renal Diagnostics. Clinical Chemistry, Volume 71, Issue 12, December 2025, Pages 1281–1282. https://doi.org/10.1093/clinchem/hvaf106

Published Dec. 4, 2025In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss Protecting Access to Medicare Act (PAMA) reform and the first reported death from alpha-gal syndrome. Later, Dr. Pritt welcomes Chris Garcia, M.D., Mayo Clinic Laboratories' chief digital innovation officer and medical director of BioPharma Diagnostics, to explore how biopharma diagnostics advance research and development. PAMA reform update (00:33): Get the latest on where reform to PAMA stands following the federal government's reopening.Alpha-gal syndrome case (03:22): Learn about the first known death from alpha-gal syndrome and diagnostic testing for this tick-bite-triggered red meat allergy.Biopharma's role in research and development (07:52): Discover how biopharma diagnostics fuel innovation and how digital tools are expanding its future impact.  Note: Information in this post was accurate at the time of its posting.ResourcesBioPharma Diagnostics: Connecting pharma and biotechTick-borne disease: An expanding geographic threat

Send us a textIn this episode of Vet Life Reimagined, Dr. Eve Hanks, BVM&S, CertAVP (EM), PhD, FRCVS, takes us inside the emerging world of microRNA diagnostics, a technology that could transform how veterinarians detect and manage disease across species.Dr. Hanks' journey is remarkable: from becoming a single mom at 19, to mixed animal practice, to discovering a passion for research, and ultimately founding MiRNA, a biotech company advancing early-detection diagnostics in animals.Eve explains what microRNAs are, why they represent a major leap forward in precision medicine, and how this technology may allow veterinarians to identify chronic disease earlier and improve outcomes for both companion and production animals. She also shares honest insights about leadership, resilience, and what it really takes to build a mission-driven company from the ground up.This conversation blends science, innovation, and career inspiration — a must-listen for anyone curious about the future of veterinary medicine.Resources:Episode on YouTubeMiRNA websiteMiRNA on LinkedInGet your gift guide here. Support the showMore Vet Life Reimagined?

Con Hermano IsaiasIEPDE.comEsperanzaConJesus.comGloriosoDerramamiento.com

Join us as we sit down with Joey Henderson, better known as Joe Joe the HVAC Man, to explore the art and science of invasive diagnostics in the HVAC industry. With decades of experience and a passion for training, Joe Joe shares his expertise on how technicians can elevate their skills and improve system performance. We dive into: • The importance of understanding saturation temperatures over pressures in diagnostics • How proper airflow and clean components are the foundation of system efficiency • Techniques for using temperature measurements to diagnose systems without gauges • The evolution of refrigerants and their impact on system design and performance • Practical tips for identifying restrictions, optimizing airflow and ensuring accurate commissioning Joey provides actionable advice and takeaways for HVAC technicians, trainers and industry pros looking to refine their diagnostic approach and deliver top-notch service. Whether you're a seasoned tech or just starting out, this episode is a must-listen for anyone passionate about the HVAC trade. Reach out to Joe Joe at joejoethehvacman@gmail.com.

In this episode of The Digital Executive, host Brian Thomas sits down with Dr. Hany Demian, physician innovator, regenerative medicine pioneer, and CEO of the Biop Spine Institute. With over 20 years of experience treating chronic pain, Dr. Demian has shifted away from traditional pain management toward a groundbreaking model that blends AI-driven diagnostics, cellular-level therapies, and microinvasive procedures—all aimed at restoring the body rather than simply masking symptoms.Dr. Demian shares the personal and professional turning point that pushed him to transform his approach: patients repeatedly returning with the same pain, coupled with his own struggles with chronic spine and joint issues. This inspired his mission to move beyond management and into true healing. Today, his clinics combine biologic treatments such as stem cells, PRP, and peptides with data-guided rehabilitation and AI-based predictive modeling that assesses lifestyle, genetics, wearables, inflammation markers, and more.He explains how AI is unlocking unprecedented insights—predicting who will develop back pain, how quickly degeneration will occur, and which interventions will work best. Inspired by early breakthroughs in AI-driven cardiac prediction, Dr. Demian believes spine and joint care will soon shift from reactive to proactive, catching problems 5–10 years before they become symptomatic.Looking ahead, Dr. Demian envisions a radical shift in musculoskeletal care:Regenerative therapies as first-line treatmentNear elimination of traditional pain clinicsFewer surgeries due to earlier detection and cellular repairWidespread reversal of aging-related degenerationHe predicts a future where aging becomes a “modifiable condition,” supported by advanced stem cell treatments, peptides, exosomes, genetic insights, and healthier lifestyle habits now emerging in younger generations.Dr. Demian's optimistic, science-backed vision points toward a world where chronic pain is rare, mobility is preserved, and humans age healthier and stronger than ever before.A fascinating conversation for anyone interested in regenerative medicine, longevity, AI in healthcare, and the future of pain-free living.If you liked what you heard today, please leave us a review - Apple or Spotify.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

- Updates on AI Tools and Book Generator (0:10) - Health Advice and Lifestyle Habits (1:42) - Critique of Conventional Doctors (6:50) - The Rise of AI in Healthcare (10:05) - Better Than a Doctor AI Feature (17:24) - Health Ranger's AI and Robotics Projects (36:07) - Philosophical Discussion on AI and Human Rights (1:10:58) - The Future of AI and Human Interaction (1:17:53) - The Role of AI in Survival Scenarios (1:18:57) - The Potential for AI in Enhancing Human Life (1:19:13) - Personal Experience with AI and Health Data (1:19:32) - AI in Diagnostics and Natural Solutions (1:22:17) - Critique of Google and AI Ethics (1:25:00) - Impact of AI on Human Relationships and Society (1:30:24) - Debate on Consciousness and AI (1:35:54) - Historical and Scientific Perspectives on Consciousness (1:50:21) - Practical Applications and Future of AI (1:53:17) For more updates, visit: http://www.brighteon.com/channel/hrreport  NaturalNews videos would not be possible without you, as always we remain passionately dedicated to our mission of educating people all over the world on the subject of natural healing remedies and personal liberty (food freedom, medical freedom, the freedom of speech, etc.). Together, we're helping create a better world, with more honest food labeling, reduced chemical contamination, the avoidance of toxic heavy metals and vastly increased scientific transparency. ▶️ Every dollar you spend at the Health Ranger Store goes toward helping us achieve important science and content goals for humanity: https://www.healthrangerstore.com/ ▶️ Sign Up For Our Newsletter: https://www.naturalnews.com/Readerregistration.html ▶️ Brighteon: https://www.brighteon.com/channels/hrreport ▶️ Join Our Social Network: https://brighteon.social/@HealthRanger ▶️ Check In Stock Products at: https://PrepWithMike.com

Today I'm joined by Henry O'Connell, CEO & Founder of Canary Speech, the company pioneering AI-powered vocal biomarkers to detect diseases like Alzheimer's, Parkinson's, and other neurological and behavioural conditions, all through a 20–30 second voice sample.In this episode, we explore:How Canary Speech was founded and where the idea came fromWhy holding 14 patents in vocal biomarker technology is such a competitive advantageHow Canary ensures clinical-grade safety, trust, and bias mitigation in AI healthcare toolsThe latest innovations in aggression detection, neurological disorders & behavioural healthHow global regulation (U.S. vs Europe vs Asia) shapes adoption speed in healthcare AIIf you're interested in AI, healthcare, digital biomarkers, clinical innovation, or the future of diagnostics, this episode is a must-listen.

People want continuous access to health data. The company's raise highlights this growing trend. Analysts expect more mega-rounds soon.Get the top 40+ AI Models for $20 at AI Box: ⁠⁠https://aibox.aiAI Chat YouTube Channel: https://www.youtube.com/@JaedenSchaferJoin my AI Hustle Community: https://www.skool.com/aihustleSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Dr. Paul Beresford, Senior Vice President of Biopharma Partnerships at PathAI, shares perspectives on how artificial intelligence is transforming pathology workflows, enhancing diagnostic accuracy, and supporting precision medicine. Discover practical insights on AI integration, regulatory alignment, and the evolving partnership between technology and clinical expertise in diagnostics.Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIAFeatured Speaker: Paul Beresford, Ph.D., Senior Vice President of Biopharma Partnerships, PathAI

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com Diagnostic intelligence is transforming healthcare by turning lab testing from a cost center into a strategic asset.  In this episode, Dr. Julie Schulz, Vice President of Product at Avalon Healthcare Solutions, discusses how integrating diagnostics into value-based care can lead to improved quality, lower costs, and enhanced preventive medicine. She notes that physicians are overwhelmed by the rapid growth of genetic testing and evolving clinical guidelines, leading to cognitive overload and inefficiencies. Diagnostic intelligence, she explains, can alleviate this by identifying the right tests at the right time and automating prior authorizations, reducing treatment timelines from 60 days to just 15. Dr. Schulz emphasizes that diagnostics inform 70% of healthcare decisions, making their effective use vital for improving access and outcomes, particularly among underserved populations, and underscores that simplifying data and embedding clinical decision support earlier can benefit both patients and providers. Tune in and learn how diagnostic intelligence is shaping the future of precision medicine and preventive care! Resources Connect with and follow Dr. Julie Schulz on LinkedIn. Follow Avalon Healthcare Solutions on LinkedIn and explore their website. Read Avalon Healthcare Solutions' Annual Lab Trend Report here.

Tina Liedtky, President of Transplant Diagnostics at Thermo Fisher Scientific, identifies the significant challenges in the US organ transplant system that must be addressed to meet the demand for organs.  Patient access to transplant care is hindered by geography, the need to match donors and recipients, and the threat of organ rejection. Living donations, particularly of kidneys and livers, are a solution to address the organ shortage, as organs from living donors often lead to better outcomes and can be scheduled to avoid damage caused by organ transportation. Tina explains, "So first of all, I would say that organ transplantation saves thousands of lives a year and gives patients with end-stage organ disease the ability to extend their lives meaningfully for many years. However, the organ transplant system in the US is not perfect, and it faces several real challenges. The most pressing challenge is a persistent imbalance between organ supply and demand, in that far more patients are in need of a lifesaving transplant than there are available organs, which leaves many patients waiting too long for a compatible organ or perhaps will never receive a compatible match. And unfortunately, for those patients left waiting, many get sicker, and often patients die while waiting on the wait list. So this gap in supply and demand is real, and it underscores the importance of living donation, which can help expand the pool of available organs and give patients a chance at the timely care that they need." "Another significant challenge is patient access to organ transplant care. For instance, in the weeks leading up to the transplant procedure and after the procedure, patients are often required to be living or situated near the hospital or the transplant center where the surgery is performed. This can pose a challenge to those who simply don't reside in areas where there are major transplant centers or who can't afford temporary housing. And that creates a socioeconomic inequity when it comes to access." #ThermoFisherScientific #Transplantation #OrganDonors #LivingDonation #HeartTransplant #OrganTransplants thermofisher.com Download the transcript here

Tina Liedtky, President of Transplant Diagnostics at Thermo Fisher Scientific, identifies the significant challenges in the US organ transplant system that must be addressed to meet the demand for organs.  Patient access to transplant care is hindered by geography, the need to match donors and recipients, and the threat of organ rejection. Living donations, particularly of kidneys and livers, are a solution to address the organ shortage, as organs from living donors often lead to better outcomes and can be scheduled to avoid damage caused by organ transportation. Tina explains, "So first of all, I would say that organ transplantation saves thousands of lives a year and gives patients with end-stage organ disease the ability to extend their lives meaningfully for many years. However, the organ transplant system in the US is not perfect, and it faces several real challenges. The most pressing challenge is a persistent imbalance between organ supply and demand, in that far more patients are in need of a lifesaving transplant than there are available organs, which leaves many patients waiting too long for a compatible organ or perhaps will never receive a compatible match. And unfortunately, for those patients left waiting, many get sicker, and often patients die while waiting on the wait list. So this gap in supply and demand is real, and it underscores the importance of living donation, which can help expand the pool of available organs and give patients a chance at the timely care that they need." "Another significant challenge is patient access to organ transplant care. For instance, in the weeks leading up to the transplant procedure and after the procedure, patients are often required to be living or situated near the hospital or the transplant center where the surgery is performed. This can pose a challenge to those who simply don't reside in areas where there are major transplant centers or who can't afford temporary housing. And that creates a socioeconomic inequity when it comes to access." #ThermoFisherScientific #Transplantation #OrganDonors #LivingDonation #HeartTransplant #OrganTransplants thermofisher.com  Listen to the podcast here

Neda Nikpoor, MD, and Neda Shamie, MD, reframe refractive surgery as a comprehensive vision-correction mindset rather than a single procedure, exploring how advanced diagnostics and disciplined risk stratification guide candidacy and smart decision-making across refractive options. They outline when to pivot—or defer—and emphasize expectation-setting, patient motivation, and screening for medical and psychosocial factors that influence satisfaction.

Unnecessary broad-spectrum antibiotics can drive antimicrobial resistance and cause adverse events, whereas inadequate antibiotic coverage is linked to increased mortality and length of stay for patients with bloodstream infections (BSIs). Listen now to learn from Jose Alexander, MD, D(ABMM), CIC, FCCM, SM/MB(ASCP), how to use rapid genotypic and phenotypic antimicrobial susceptibility testing results to inform antibiotic selection for patients with gram-negative BSIs. Topics covered include:Typical patterns of intrinsic antibiotic susceptibility and resistance in EnterobacteralesMechanisms of resistance in gram-negative bacteriaGenotypic rapid diagnostic tests for BSIsResistance markers for earlier targeted therapyRapid phenotypic antimicrobial susceptibility test platforms for blood culturesPresenter:Jose Alexander, MD, D(ABMM), CIC, FCCM, SM/MB(ASCP)Medical and Public Health MicrobiologistMedical and Technical Director of MicrobiologyAdventHealthOrlando, FloridaLink to full program and downloadable slides:https://bit.ly/4inoXCxGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Rapid phenotypic antimicrobial susceptibility testing (AST) significantly reduces time to actionable results and can improve antibiotic decision-making for patients with bloodstream infections. Listen in to learn from Michael P. Veve, PharmD, MPH, how to optimally integrate rapid phenotypic AST into clinical practice, including incorporation into your existing antimicrobial stewardship workflow. Topics covered include:Considerations for implementationDecision-making steps for implementationThe role of antimicrobial stewardship programs in AST workflowPresenter:Michael P. Veve, PharmD, MPHClinical Associate ProfessorDepartment of Pharmacy PracticeEugene Applebaum College of Pharmacy and Health SciencesWayne State UniversityClinical Pharmacy Specialist, Infectious DiseaseHenry Ford HospitalDetroit, MichiganLink to full program and downloadable slides:https://bit.ly/4inoXCxGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Sepsis and bloodstream infections (BSIs) are common and cause millions of deaths each year, with a disproportionate burden in low-income and middle-income countries. Tune in to learn from Jasmine R. Marcelin, MD, FACP, FIDSA, how inadequate antibiotic coverage can be linked to increased mortality and length of stay and how unnecessary broad-spectrum antibiotics can drive antimicrobial resistance. Topics covered include:The worldwide burden of sepsis and BSIsThe ongoing threat of antimicrobial resistanceUS and global health disparities in sepsis, BSI, and antimicrobial resistanceBarriers toward optimizing antibiotic use in BSIsPresenter:Jasmine R. Marcelin, MD, FACP, FIDSAAssociate Professor, Infectious DiseaseAssociate Medical Director, Antimicrobial Stewardship ProgramVice Chair for Belonging and Community Engagement, Department of Internal MedicineCo-Director, Digital Innovation & Social Media Strategy, Division of Infectious DiseasesUniversity of Nebraska Medical CenterOmaha, NebraskaLink to full program and downloadable slides:https://bit.ly/4inoXCxGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Download our “Tell a Better Story, Win Better Clients” E-book at https://working-towards.com/Dr. John Heinlein, Chief Marketing Officer at Sonatus, a global leader in vehicle software powering the shift toward software defined vehicles (SDVs) and AI-driven automotive innovation.John brings a unique blend of deep engineering expertise — with degrees from Carnegie Mellon University and a Ph.D. in Electrical Engineering from Stanford — and more than two decades of senior leadership across marketing, automotive technology, business development, and system architecture.We dig into:• How SDVs work and why vehicles are becoming more like data centers• The transition from 150+ hardware ECUs to flexible, upgradeable software platforms• How automakers harness vehicle data, intelligence, and AI to improve performance• The infrastructure needed to support next generation automotive experiences• The explosive role of AI in vehicle optimization, diagnostics, and personalization• Why the automotive industry is attracting top engineering talent again• Sonatus' rapidly growing footprint in more than 5 million production vehicles (soon to be 6 million)• The behind-the-scenes look at building a modern automotive software stackJohn also hosts The Garage by Sonatus, where he interviews top minds in vehicle software and mobility innovation.⸻Guest LinksWebsite: https://www.sonatus.com/LinkedIn: https://www.linkedin.com/in/johnheinlein/The Garage Podcast (YouTube): https://www.youtube.com/playlist?list=PL02SS1Fp5GCjBUmXe4eTnEVdDLDViQXR2

About Dr. Julie Schulz:Dr. Julie Schulz, MD, MPH, is a physician executive and product leader based in Los Angeles with a proven track record of driving innovation at the intersection of healthcare, technology, and business. Over the past 15 years, she has built and led teams developing healthcare decision support, analytics, and consumer health products across value-based care, women's health, and life sciences. As VP of Product at Avalon Healthcare Solutions, she leads strategy for next-generation diagnostics platforms. Previously, at HALO Diagnostics and Doctor Evidence, she guided product and business development efforts that integrated imaging, laboratory, and evidence-based analytics to improve patient and physician experiences. Earlier roles at Lumere and Sg2 honed her expertise in clinical data, product-market fit, and scaling evidence-driven solutions. Published in leading journals, Dr. Schulz combines deep clinical insight with strategic leadership to advance innovations that improve healthcare outcomes and drive measurable business impact.Things You'll Learn:Diagnostic intelligence can transform diagnostics from a cost center into a strategic asset that improves quality and lowers costs.Physicians face overwhelming volumes of new tests and guidelines, and AI-powered decision support can ease their cognitive burden.By removing prior authorization barriers, patients can transition from diagnosis to treatment in just 15 days, rather than the typical 60 days.Data shows that healthier patients are more likely to receive GLP-1 prescriptions, revealing a need for better risk-adjusted care strategies.True innovation in healthcare depends on communication, simplifying complexity and aligning clinicians, payers, and technologists toward shared goals.Resources:Connect with and follow Dr. Julie Schulz on LinkedIn.Follow Avalon Healthcare Solutions on LinkedIn and explore their website.Read Avalon Healthcare Solutions' Annual Lab Trend Report here.

Like the show? Show your support by using our sponsors.Promotive can help you find your dream job. Touch HERE to see open jobs.Need to update your shop systems and software? Try Tekmetric HERERegister for Tektonic HERE!In this episode, Jeff Compton welcomes Chuck Mitchell, this year's APPEX Giveaway Winner from the Changing the Industry Podcast with Lucas Underwood and David Roman. Chuck shares his story of how he got into the industry from fleet management and parts retail to shop ownership. He's passionate about the current technician shortage and helping younger generations. He and Jeff talk about the importance of cross-industry collaboration among local shops, the need for better training and information access, and the value of mentoring new technicians to create a more sustainable future for the automotive industry.Timestamps: 00:00 Meet Chuck Mitchell06:39 "Friend's Growth in Dealerships"15:05 Balancing Business and Compassion17:06 Shop Ownership Challenges22:58 "Building Confidence Through Understanding"30:19 Improving Industry and Supporting Workers34:07 Tech Career Paths in Shops36:44 "EV Direction and Innovation"43:25 "Reviving Craftsmanship in Auto Industry"48:24 "Vehicle Repair Challenges Persist"52:18 Customer Service and Accountability01:00:09 "AI, VR, and Cost Challenges"01:03:39 "Nurturing Young Techs"01:11:31 "Industry Growth Through Connection" Follow/Subscribe to the show on social media! TikTok - https://www.tiktok.com/@jeffcompton7YouTube - https://www.youtube.com/@TheJadedMechanicFacebook - https://www.facebook.com/profile.php?id=100091347564232

Na raming maak 58 persent van Namibië se werksmag hul bestaan uit die informele sektor. Dit is onthul deur die uitvoerende direkteur in die ministerie van finansies, Michael Humavindu. Humavindu het vanoggend tydens die bekendstelling van die verslag getiteld Diagnostics of Informality in Namibia gesê dat die informele sektor se bydrae tot die BBP teen 2025 op 26,5 persent staan. Ten spyte hiervan het hy gesê dat die sektor tans in 'n baie bestraffende regulatoriese omgewing funksioneer, nie as 'n vennoot wat bemagtig moet word nie.

Today my guest is Dr Osama Khan from Natera What we discuss with Dr Khan : His journey into pathology The importance of mentorship in pathology Pathology at the intersection of diagnostics and precision medicine The collaborative nature of pathology Transitioning from academia to industry Natera and Cell-Free DNA Testing Understanding Circulating Tumor DNA (CtDNA) The role of MRD Testing in cancer treatment Personalized testing and tumor informed tests His thoughts on AI in pathology His advice for aspiring pathologists Links for this episode: InVision from Cision Vision The Path to PathA Pathologists' Assistant Shadowing Network Health Podcast Network  LabVine Learning Dress A Med scrubs Digital Pathology Club   Natera Osama Khan: The critical importance of embracing AI and digital workflows in medical practice   People of Pathology Podcast: Twitter Instagram

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, welcomes William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories. Together, they discuss recent news about virus activity and explore the value of collaboration in shaping innovative diagnostic strategies.   Testing for viruses appearing closer to home (00:45): Gain insights on using available testing to manage measles and detect chikungunya, which was recently transmitted in the U.S. for the first time in years. Collaborating for more coordinated care and innovation (06:04): Explore how strategic partnerships in diagnostics foster innovation and enable a more integrated approach to clinical decision-making.Building successful collaborations (12:16): Discover practical insights into establishing and maintaining collaborations that deliver meaningful value to all involved. Note: Information in this post was accurate at the time of its posting.ResourcesAnswers From the Lab Podcast: How the Evolving Role of Diagnostics and Platforms Impact Healthcare: Bill Morice, M.D., Ph.D. Dr. Bill Morice shares how a platform for collaboration transforms diagnosticsMary Jo Williamson offers four steps to maximize collaboration benefits

In this foundational episode of the TriMetric Roadmap Podcast, Scott Landis and Jeff Jacob officially launch the show and dive deep into the Business Health Diagnostic™ (BHD) — a proprietary system that helps founders measure and improve the true health, value, and freedom potential of their business. They unpack the why, what, and how behind the diagnostic — from discovering operational blind spots to uncovering hidden valuation opportunities — and show how the BHD fits inside Business Freedom Advisors' Freedom 360™ program. The conversation flows from practical business strategy into spiritual insight, revealing how freedom in business connects to fulfillment in life. -- Key Themes Start with WHY: The Business Health Diagnostic helps founders move from chaos to clarity — and from job ownership to true business freedom. Faith Meets Finance: Jeff and Scott discuss the intersection of purpose, stewardship, and intelligent financial design. From Valuation to Vision: Why good exit planning is also good business planning — and how to build transferable value even if you never plan to sell. Numbers with a Story: Recasting financials isn't about accounting tricks; it's about revealing the truth of what your business is really worth. Freedom 360™: How the BHD anchors a broader suite of tools — the Business Intelligence Briefing™, Executive Field Manual™, and Tax Briefing™ — to drive freedom and profitability within 90 days. -- Resources Mentioned

Send us your desired health topic or guest suggestionsWhat if your symptoms aren't random but signals asking for better inputs? We sit down with Dr. Alexandra Geyer, an emergency physician turned metabolic health expert, to map a clear route from “normal labs” to real recovery. Her story of hitting a wall during residency and rebuilding health informs a practical, hopeful framework that blends advanced diagnostics, evidence-backed peptides, and everyday habits that actually stick.Dr. Geyer explains why metabolic health is the engine for energy, mood, sleep, and longevity, and how to measure it beyond the scale.  We then widen the lens to hormone health, including free T3 and thyroid antibodies to catch early Hashimoto's, plus sex hormones that determine drive and resilience. The message is simple: when you fix the signals, action feels possible again.Peptides step in as precision tools, not magic bullets. You'll hear how BPC-157 calms inflammation and supports tissue repair so movement stops hurting; how Selank and Semax lower neuroinflammation, lift BDNF, and restore calm focus; and how Pinealon can reset circadian rhythm with a short, yearly cycle. Safety comes first: no black-market sourcing, strict sterility and purity testing, and clear contraindications for cancer and pregnancy. We also dive into gut microbiome testing to address stubborn symptoms and the role of micronutrients when convenience foods drain capacity.By the end, you'll have a grounded plan: build lean muscle, favor whole foods that don't hijack appetite, test what matters, repair the gut, and use targeted peptides to amplify the good habits you're already trying to keep. Ready to trade quick fixes for lasting change? Follow, share with a friend who needs hope, and leave a review telling us which test or habit you'll start this week.You can find Alexsandra Gajer at:Website - https://thegajerpractice.com/ Please Follow and Review this podcast if you would like to support the growth of this show. Thank You! :)If you enjoyed this episode, please consider sharing it with two people you know that might benefit from the information. The more knowledge that people have in their hands, the healthier we can all become. If you would like to see a particular health issue discussed, or know someone who would be a great guest, contact the Open-Minded Healing podcast at openmindedhealing365@gmail.com. Note: By listening to this podcast, you agree not to use this podcast as medical advice to treat any medical condition in either yourself or others, including but not limited to patients that you are treating. Consult your own physician for any medical issues that you may be having. This entire disclaimer also applies to any guests or contributors to the podcast. Under no circumstances shall Marla Miller, Open-Minded Healing Podcast, any guests or contributors to the podcast, be responsible for damages arising from use of the podcast.

Today on Sauna Talk, we are joined by the dynamic duo of researcher from Emery University, Deanna Kaplan and Roman Palitsky. Deanna Kaplan Deanna Kaplan, PhD is a clinical psychologist with expertise in digital health technologies. She has more than a decade of experience using wearable and smartphone-based technologies to study the dynamics of health processes and clinical change during daily life. Her research is grounded in a whole-person (bio-psycho-social-spiritual) model of health, and much of her work focuses on investigating the dynamics of change of integrative interventions, such as psychedelic-assisted therapies and contemplative practices. Dr. Kaplan is the Director of the Human Experience and Ambulatory Technologies (HEAT) Lab, a multidisciplinary collaboration between the Department of Family and Preventive Medicine and Emory Spiritual Health. More information about the HEAT Lab is here. Dr. Kaplan is the co-creator and Scientific Director of Fabla, an unlicensed Emory-hosted app for multimodal daily diary and ecological momentary assessment (EMA) research. Fabla is an EMA app that can securely collect voice-recorded, video-recorded , and photographic responses from research participants. More information about Fabla is here. Dr. Kaplan holds an adjunct appointment in Emory's Department of Psychology and is appointed faculty for several Emory centers, including the Winship Cancer Institute, Emory Spiritual Health (ESH), the Emory Center for Psychedelics and Spirituality (ECPS), and the Advancement of Diagnostics for a Just Society (ADJUST) Center. She also holds an appointment as an adjunct Assistant Professor at Brown University in affiliation with the Center for Digital Health. Dr. Kaplan received her PhD in Clinical Psychology from the University of Arizona, completed her predoctoral clinical internship at the Alpert Medical School of Brown University, and completed a postdoctoral research fellowship at Brown University, where she received an F32 National Research Service Award (NRSA) from the National Institutes of Health (NIH). Her research is funded by the NIH, the Health Resources Services Administration (HRSA), the Georgia Clinical and Translational Science Alliance, the Tiny Blue Dot Foundation, and the Vail Health Foundation among others. She was named as a 2025 Rising Star by Genomics Press for her work in mental health assessment innovation. Roman Palitsky Roman Palitsky, MDiv, Ph.D. is Director of Research Projects for Emory Spiritual Health and a Research Psychologist for Emory University School of Medicine. His research program investigates the pathways through which culture and health interact by examining the biological, psychological, and social processes that constitute these pathways. His areas of interest include biopsychosocial determinants in cardiovascular health, chronic pain, and grief. In collaboration with Emory Spiritual Health, his research addresses cultural and existential topics in healthcare such as religion, spirituality, and the way people find meaning in suffering, as they relate to health and illness. His work has also focused on the role of religious and existential worldviews in mindfulness-based interventions, as well as implementation and cultural responsiveness of these interventions. Dr. Palitsky's academic training includes a PhD in Clinical Psychology from the University of Arizona with a concentration in Behavioral Medicine/Health Psychology, and a Master of Divinity from Harvard University. He completed clinical internship in the behavioral medicine track at Brown University Warren Alpert Medical School, where he also completed a postdoctoral fellowship. Deanna and Roman were in town attending and speaking at the 2025 SSSR Conference, Society for the Scienific Study of Religion. And as you will hear, we get deep into the spirit of sauna, a spiritual connection we allow ourselves to have, presented to us through the wonderfulness of time on the bench and chilling out in the garden, all misty wet with rain.

Traditional MRIs often miss the real causes of neck pain because scans are taken while patients are lying down—not how they live or move every day. This new technology can reveal hidden issues like stenosis and radiculopathy that only show up when you're upright and in motion.Episode Notes: Weight-bearing MRI of the cervical spine: A scoping review of clinical utility and emerging applicationsLeander Tables- Save $1,000 on the Series 950 Table using the code EBC2025 — their most advanced flexion-distraction tablePatient Pilot by The Smart Chiropractor is the fastest, easiest to generate weekly patient reactivations on autopilot…without spending any money on advertising. Click here to schedule a call with our team.Our members use research to GROW their practice. Are you interested in increasing your referrals? Discover the best chiropractic marketing you aren't currently using right here!

Our guest, Hunter Ziesing shares his work with AI in assisting individuals in their quest for health and longevity.   Hunter spent the bulk of his career in investment banking focusing on the Healthcare, Consumer, and Technology areas. He was the founder of Charity of Choice, a non-profit focused on cancer research and health prevention. Early Overall Outcomes Biomarker Improvements A majority of patients showed significant movement in at least one critical biomarker (ApoB, VAT, bone density, VO2Max, HbA1c). ~80% improved at least one key biomarker. Common improvements included reductions in ApoB, decreases in visceral fat (VAT), and gains in lean mass/bone density. Major Findings from Diagnostics ~65% of patients had at least one significant finding from testing (e.g., early CAD on Cleerly, sleep apnea, insulin resistance, GI imbalances). These findings directly shaped interventions and escalations in care. Symptom Reversals ~30% experienced meaningful reversal of previously severe symptoms (e.g., hypertension control, prediabetes reversal, improved sleep apnea, reduction in chronic GI symptoms). Resources: ai.longevityhealth.me Our Sponsor: Haven Medical maker of the Cox 8 Table  

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss recent news about drug-resistant infections. Later, Paul Jannetto, Ph.D., director of the Clinical and Forensic Toxicology Lab, Clinical Mass Spectrometry Lab, and Metals Lab, joins Dr. Pritt for the deep dive segment. Together, they explore how diagnostics are shaping the future of therapeutics.  New podcast format launch (00:25): Drs. Morice and Pritt introduce the exciting new format for “Answers From the Lab,” including the addition of in-depth expert segments.   Drug-resistant infections (02:05): Discover how clinical diagnostics play a critical role in combating the growing threat of antibiotic resistance. Diagnostics' role in advancing precision medicine (13:28): Learn how diagnostics, specifically drug monitoring, are advancing personalized therapies and contributing to better outcomes. Note: Information in this post was accurate at the time of its posting. Resources Therapeutics testing: A clear path to accurate answers Therapeutics testing at Mayo Clinic Laboratories WHO warns of widespread resistance to common antibiotics worldwide Tests for infectious disease detection and identification  Connect with Us Is there a question or topic you'd like us to explore in a future episode? Email us at mayocliniclabs@mayo.edu. Learn more about our hosts and guests and connect with them on social media.  Bobbi Pritt, M.D.  Bio  |  LinkedIn Bill Morice, M.D., Ph.D. Bio  |  LinkedIn Paul Jannetto, Ph.D. Bio  |  LinkedIn

In this episode, Nick Wilson of Philips Ambulatory Monitoring and Diagnostics and Darren Batara of a leading academic medical center share how health systems can elevate cardiac care through interoperability, operational AI, and strong clinical partnerships that keep patients and clinicians at the center of innovation.This episode is sponsored by Philips.